Published in J R Stat Soc Ser A Stat Soc on April 01, 2009
Dynamic microsimulation models for health outcomes: a review. Med Decis Making (2010) 1.18
Structural and parameter uncertainty in Bayesian cost-effectiveness models. J R Stat Soc Ser C Appl Stat (2010) 0.84
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. Pharmacoeconomics (2016) 0.82
Bayesian variable selection in cost-effectiveness analysis. Int J Environ Res Public Health (2010) 0.75
Modelling survival data to account for model uncertainty: a single model or model averaging? Springerplus (2013) 0.75
Spatial prediction of N2O emissions in pasture: a Bayesian model averaging analysis. PLoS One (2013) 0.75
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet (2005) 7.47
Utilities and quality-adjusted life years. Int J Technol Assess Health Care (1989) 4.18
Handling uncertainty in cost-effectiveness models. Pharmacoeconomics (2000) 3.37
A rational framework for decision making by the National Institute For Clinical Excellence (NICE). Lancet (2002) 3.26
Model selection for extended quasi-likelihood models in small samples. Biometrics (1995) 3.01
On the decision rules of cost-effectiveness analysis. J Health Econ (1993) 2.09
Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons. Stat Med (2007) 1.90
Methods for epidemiologic analyses of multiple exposures: a review and comparative study of maximum-likelihood, preliminary-testing, and empirical-Bayes regression. Stat Med (1993) 1.88
Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Stat Med (2003) 1.84
Network information criterion-determining the number of hidden units for an artificial neural network model. IEEE Trans Neural Netw (1994) 1.82
Simulation study of hierarchical regression. Stat Med (1996) 1.39
Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis. Health Technol Assess (2004) 1.17
Aortic aneurysm diameter and risk of cardiovascular mortality. Arterioscler Thromb Vasc Biol (2001) 1.15
Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm. Br J Surg (2008) 1.13
Comparing model structures in cost-effectiveness analysis. Med Decis Making (2005) 0.82
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 12.79
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81
Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58
EuroSCORE II. Eur J Cardiothorac Surg (2012) 9.52
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med (2010) 7.83
Controlling the risk of spurious findings from meta-regression. Stat Med (2004) 6.80
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc (2009) 5.81
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA (2009) 5.63
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials (2004) 5.26
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89
Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet (2005) 3.73
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ (2011) 3.65
A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med (2007) 3.27
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials (2005) 3.19
Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation (2004) 3.07
Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med (2010) 3.07
Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial. BMJ (2014) 2.98
Bias modelling in evidence synthesis. J R Stat Soc Ser A Stat Soc (2009) 2.74
Adjusting for partially missing baseline measurements in randomized trials. Stat Med (2005) 2.70
A case-control analysis of readmissions to the cardiac surgical intensive care unit. Eur J Cardiothorac Surg (2002) 2.67
Methodological challenges in online trials. J Med Internet Res (2009) 2.64
Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol (2012) 2.58
Poorer self assessed health in a prospective study of men with screen detected abdominal aortic aneurysm: a predictor or a consequence of screening outcome? J Epidemiol Community Health (2004) 2.42
An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial. Eur Heart J (2006) 2.39
Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol (2013) 2.34
Review of statistical methods for analysing healthcare resources and costs. Health Econ (2010) 2.27
Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol (2006) 2.22
Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control (2006) 2.17
Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol (2015) 2.14
Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol (2013) 2.06
Idiopathic hypersomnia: a study of 77 cases. Sleep (2007) 1.94
Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med (2010) 1.92
Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant (2002) 1.90
Clustering by health professional in individually randomised trials. BMJ (2005) 1.85
Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol (2011) 1.75
Use of Mendelian randomisation to assess potential benefit of clinical intervention. BMJ (2012) 1.70
Impact and costs of incentives to reduce attrition in online trials: two randomized controlled trials. J Med Internet Res (2011) 1.66
Flexible parametric models for random-effects distributions. Stat Med (2008) 1.61
On-line randomized controlled trial of an internet based psychologically enhanced intervention for people with hazardous alcohol consumption. PLoS One (2011) 1.61
Instrumental variable analysis with a nonlinear exposure-outcome relationship. Epidemiology (2014) 1.58
The DYD-RCT protocol: an on-line randomised controlled trial of an interactive computer-based intervention compared with a standard information website to reduce alcohol consumption among hazardous drinkers. BMC Public Health (2007) 1.56
A randomized controlled trial of follow-up of patients discharged from the hospital following acute asthma: best performed by specialist nurse or doctor? Chest (2006) 1.54
Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol (2015) 1.51
The use of random effects models to allow for clustering in individually randomized trials. Clin Trials (2005) 1.50
Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation (2009) 1.49
Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients. Stat Med (2002) 1.47
Bias in causal estimates from Mendelian randomization studies with weak instruments. Stat Med (2011) 1.44
An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery. Anesth Analg (2015) 1.43
Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantation. Transplantation (2010) 1.41
Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus. Gastroenterology (2012) 1.37
Improving bias and coverage in instrumental variable analysis with weak instruments for continuous and binary outcomes. Stat Med (2012) 1.27
Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. Health Econ (2005) 1.25
Joint modelling of longitudinal and time-to-event data with application to predicting abdominal aortic aneurysm growth and rupture. Biom J (2011) 1.19
Uncertainty and validation of health economic decision models. Health Econ (2010) 1.17
Multiple imputation for handling systematically missing confounders in meta-analysis of individual participant data. Stat Med (2013) 1.16
Allowing for missing outcome data and incomplete uptake of randomised interventions, with application to an Internet-based alcohol trial. Stat Med (2011) 1.16
Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways? Ann Thorac Surg (2006) 1.14
Objectively measured physical activity and fat mass in children: a bias-adjusted meta-analysis of prospective studies. PLoS One (2011) 1.11
Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials. Med Decis Making (2011) 1.10
A framework for addressing structural uncertainty in decision models. Med Decis Making (2011) 1.09
A framework for quantifying net benefits of alternative prognostic models. Stat Med (2011) 1.08
Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms. J Vasc Surg (2010) 1.07
Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions. Health Qual Life Outcomes (2009) 1.07
A general goodness-of-fit test for Markov and hidden Markov models. Stat Med (2008) 1.06
Semi-Markov models with phase-type sojourn distributions. Biometrics (2010) 1.05
Allowing for imprecision of the intracluster correlation coefficient in the design of cluster randomized trials. Stat Med (2004) 1.04
Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: should it be applied to a recurrent events outcome? Stat Methods Med Res (2007) 1.03
Optimal multistage designs for randomised clinical trials with continuous outcomes. Stat Med (2011) 1.03
The rupture rate of large abdominal aortic aneurysms: is this modified by anatomical suitability for endovascular repair? Ann Surg (2008) 1.02
Surveillance intervals for small abdominal aortic aneurysms: a meta-analysis. JAMA (2013) 1.01
Prior distributions for the intracluster correlation coefficient, based on multiple previous estimates, and their application in cluster randomized trials. Clin Trials (2005) 1.01
Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol (2007) 1.01
Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? J Heart Lung Transplant (2002) 1.01
Impact of length or relevance of questionnaires on attrition in online trials: randomized controlled trial. J Med Internet Res (2011) 1.01
Preoperative risk prediction and intraoperative events in cardiac surgery. Eur J Cardiothorac Surg (2002) 0.99
Choice of test for comparing two groups, with particular application to skewed outcomes. Stat Med (2003) 0.98
Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med (2014) 0.98
Modelling multiple sources of dissemination bias in meta-analysis. Stat Med (2010) 0.97
Life-years gained by reducing donor heart ischemic times. Transplantation (2009) 0.96
Derivation and assessment of risk prediction models using case-cohort data. BMC Med Res Methodol (2013) 0.95
Assessing risk prediction models using individual participant data from multiple studies. Am J Epidemiol (2013) 0.95
Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ (2005) 0.95
Within-person variability in calculated risk factors: comparing the aetiological association of adiposity ratios with risk of coronary heart disease. Int J Epidemiol (2013) 0.94
Methods for covariate adjustment in cost-effectiveness analysis that use cluster randomised trials. Health Econ (2012) 0.94
Missing data methods in Mendelian randomization studies with multiple instruments. Am J Epidemiol (2011) 0.93
The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. J Heart Lung Transplant (2006) 0.93
Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables. Stat Med (2010) 0.93
Survival models in health economic evaluations: balancing fit and parsimony to improve prediction. Int J Biostat (2010) 0.93
Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease. Health Qual Life Outcomes (2010) 0.92